(Q62802884)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Simon R Platt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Alejandro Luján Feliu-Pascual

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lara A Matiasek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Kate E Chandler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

30 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

published in

The Veterinary Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

310-319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Epilepsy and seizure classification in 63 dogs: a reappraisal of veterinary epilepsy terminology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Levetiracetam safety profiles and tolerability in epilepsy patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Canine epilepsy: what can we learn from human seizure disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

New antiepileptic drugs: comparison of key clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Anticonvulsant therapy in dogs and cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Zonisamide therapy for refractory idiopathic epilepsy in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Fast and sustained efficacy of levetiracetam during titration and the first 3 months of treatment in refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Levetiracetam: a novel antiepileptic drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Therapeutic drug monitoring of the newer antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Long-term continuation of levetiracetam in patients with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Clinical presentations of naturally occurring canine seizures: similarities to human seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Selective blockade of N-type calcium channels by levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Antiepileptic drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Bromide therapy in refractory canine idiopathic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Clinical aspects and biological bases of drug-resistant epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Why does epilepsy become intractable? Prevention of chronic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

The neurobiology of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2007.03.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TVJL.2007.03.002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468024%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference